Table 1.
Baseline characteristics of patients
| Characteristics | n = 70 | |
| Age, yr (SD, range) | 45.9 | (15.7, 12.0-82.0) |
| Sex, male (%) | 45 | (64.3) |
| HBV/HCV/Alcohol/NAFLD/Other (%) | 23 (32.9)/18 (25.7)/12 (17.1)/4 (5.7)/13 (18.6) | |
| Body mass index, kg/m2(SD, range) | 23.8 | (2.9, 16.9-29.7) |
| Hemoglobin, g/dL (SD, range) | 12.9 | (2.2, 6.7-17.8) |
| Platelet count, 103/mm3 (SD, range) | 174.7 | (55.3, 76.0-285.0) |
| Albumin, g/dL (SD, range) | 3.9 | (0.7, 1.6-5.3) |
| AST, U/L (IQR, range) | 55 | (31-111, 13-369) |
| ALT, U/L (IQR, range) | 47 | (24-99, 6-473) |
| Total bilirubin, mg/dL (IQR, range) | 0.7 | (0.5-1.1, 0.2-4.9) |
| GGT, U/L (IQR, range) | 57 | (31-157, 13-1569) |
| Prothrombin time, INR (IQR, range) | 0.93 | (0.87-1.00, 0.76-1.48) |
| APRI (IQR, range) | 0.91 | (0.51-1.35, 0.55-5.88) |
| Hyaluronic acid1, ng/mL (IQR, range) | 62 | (23-176, 10-2796) |
| Type IV collagen1, ng/mL (IQR, range) | 182 | (117-310, 66-2790) |
| Liver stiffness by SWE, kPa (IQR, range) | 11.1 | (7.3-18.4, 4.73-48.61) |
| Fibrosis stage (%) | ||
| F0-1 | 15 | (21.4) |
| F2 | 20 | (28.6) |
| F3 | 13 | (18.6) |
| F4 | 22 | (31.4) |
1
n = 61. HBV: Hepatitis B virus; HCV: Hepatitis C virus; NAFLD: Nonalcoholic fatty liver disease; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; GGT: Gamma glutamyltranspeptidase; INR: International normalized ratio; SWE: Shear wave elastography; kPa: Kilopascals; SD:Standard deviation; IQR: Interquartile range.